Vasomotor symptoms with various tamoxifen doses

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-93396-1
中图分类号
学科分类号
摘要
引用
收藏
页码:12 / 12
相关论文
共 50 条
  • [41] RESPONSE OF HUMAN ENDOMETRIAL CARCINOMA TO VARIOUS DOSES OF ESTRADIOL AND TAMOXIFEN IN THE NUDE-MOUSE MODEL
    MORTEL, R
    ZAINO, RJ
    SATYASWAROOP, PG
    GYNECOLOGIC ONCOLOGY, 1985, 20 (02) : 257 - 257
  • [42] Exercise for vasomotor menopausal symptoms
    Daley, A.
    MacArthur, C.
    Mutrie, N.
    Stokes-Lampard, H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
  • [43] Continuing progress on vasomotor symptoms
    Barlow, David H.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (03): : 235 - 236
  • [44] Phytoestrogens for menopausal vasomotor symptoms
    Lethaby, Anne
    Marjoribanks, Jane
    Kronenberg, Fredi
    Roberts, Helen
    Eden, John
    Brown, Julie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [45] Nonhormone treatments for vasomotor symptoms
    Carpenter, Janet S.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2025, 32 (02): : 174 - 175
  • [46] Cortisol awakening response differs for midlife women with objective vasomotor symptoms versus without vasomotor symptoms
    Rubin, Leah H.
    Drogos, Lauren L.
    Kapella, Mary C.
    Geller, Stacie E.
    Maki, Pauline
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1362 - 1362
  • [47] Clinical trials of tamoxifen at low doses
    Decensi, AU
    Bonanni, B
    Cazzaniga, M
    Gonzaga, AG
    Serrano, D
    Lazzeroni, M
    Macis, D
    Feroce, I
    Pizzamiglio, M
    Oldani, S
    Gandini, S
    Veronesi, U
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1963S - 1963S
  • [48] Perimenopausal migraine in women with vasomotor symptoms
    MacGregor, E. Anne
    MATURITAS, 2012, 71 (01) : 79 - 82
  • [49] Soy for bone protection and vasomotor symptoms
    Pines, Amos
    CLIMACTERIC, 2011, 14 (06) : 694 - 695
  • [50] Fezolinetant (Veozah) for Menopausal Vasomotor Symptoms
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1679): : 97 - 99